Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 31;7(4):137-142.
doi: 10.2478/jtim-2019-0028. eCollection 2019 Dec.

Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear

Affiliations
Review

Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear

Arefeh Babazadeh et al. J Transl Int Med. .

Abstract

Guillain-Barré syndrome (GBS) is an inflammatory disorder and an acute immune-mediated demyelinating neuropathy that causes reduced signal transmissions, progressive muscle weakness, and paralysis. The etiology of the syndrome still remains controversial and uncertain. GBS can be initiated and triggered by respiratory tract infections such as influenza, and intestinal infections such as Campylobacter jejuni. In addition, there is considerable evidence suggesting links between influenza vaccination and GBS. As reported previously, the incidence of GBS in individuals receiving swine flu vaccine was about one to two cases per million. Despite the influenza vaccine efficacy, its association with an immune-mediated demyelinating process can be challenging as millions of people get vaccinated every year. In this review we will discuss the association between influenza infection and vaccination with GBS by focusing on the possible immunopathological mechanisms.

Keywords: Guillain–Barré syndrome; flu vaccination; influenza.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest There are no conflicts of interest.

Similar articles

Cited by

References

    1. Goodfellow JA, Willison HJ. Guillain–Barré syndrome: a century of progress. Nat Rev Neurol. 2016;12:723–31. - PubMed
    1. Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya J-M, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12:1175–89. - PubMed
    1. Tandel H, Vanza J, Pandya N, Jani P. Guillain-barré syndrome (GBS) A Review. 2016:366–71.
    1. Galeotti F, Massari M, D’Alessandro R, Beghi E, Chiò A, Logroscino G. et al. Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol. 2013;28:433–44. - PMC - PubMed
    1. Wang YZ, Lv H, Shi QG, Fan XT, Li L, Yi Wong AH. et al. Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome. Sci Rep. 2015;5:13931. - PMC - PubMed

LinkOut - more resources